News
Kairos Power has installed the reactor vessel for its third Engineering Test Unit, which is under construction in Oak Ridge, ...
Kairos Pharma reported strong safety results from a Phase 2 trial of ENV-105 in mCRPC, with no serious toxicities seen in the ...
Carotuximab plus Erleada proved safe in the first 10 patients with metastatic castration-resistant prostate cancer dosed on ...
1d
InvestorsHub on MSNKairos Pharma Shares Surge on Promising Safety Data for Prostate Cancer TreatmentKairos Pharma Ltd (NYSE:KAPA) saw its stock jump 165% following the announcement of encouraging safety results from its ongoing Phase 2 clinical trial of ENV-105 in patients battling metastatic ...
Affiliates of Harbor Group International LLC (HGI) have provided a $38.3 million loan for the refinancing of a 12-story office building located at 1250 Eye St. in Washington, D.C.’s East End district.
Kairos Pharma shares were higher as the company reported positive safety results from a clinical trial of ENV-105, or carotuximab, in patients with metastatic castration-resistant prostate cancer.
Kairos Pharma, Ltd. (NYSE American:KAPA), a clinical-stage biopharmaceutical company focused on innovative cancer therapeutics, today announces participation and presentation at the H.C. Wainwright ...
Like most open-world games, Borderlands 4 will have its fair share of collectibles to hunt down. The catch here is that ...
Kairos Investment Management Co. purchased the 1980s-era building at the end of 2023 for athird of its prior sale price.
The ancient Greeks didn’t see time the way we do. There’s a lot to learn from their approach. Do you suffer from time ...
Kairos Pharma, Ltd. (NYSE American:KAPA), a clinical-stage biopharmaceutical company focused on innovative cancer therapeutics, today announces positive safety results from its ongoing Phase 2 ...
Kairos Investment Management landed a $38.3 million senior loan from Harbor Group International (HGI) for 1250 I Street NW, a ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results